CD274 and COVID-19: A case of immune-mediated pneumonia in a 65-year-old patient with head and neck squamous metastatic cancer was reported, who recovered from COVID-19 and received combination therapy, including PD-L1 inhibitors; however, without any clinical manifestations, the pulmonary toxic event was classified as grade 1.